Wild headlines are emerging throughout TV and in the press about a “super COVID killer vaccine” developed by the US Department of Defense against COVID-19 that promises to be a “pan-coronavirus” treatment for all variants of the virus, the current and future ones. There’s no lack of hyped claims surrounding the supposed super jab, but to date, there has been no evidence presented.
The DOD’s Walter Reed Army Institute of Research (WRAIR) is currently on a press tour for the initial results of the Phase 1 test for their Spike Ferritin Nanoparticle COVID-19 vaccine, alternatively known as SpFN.
The reports from media states that:
“Within weeks, scientists at the Walter Reed Army Institute of Research expect to announce that they have developed a vaccine that is effective against COVID-19 and all its variants, even Omicron, as well as from previous SARS-origin viruses that have killed millions of people worldwide.”
The military issued a press release regarding its nanoparticle COVID vaccine on December 16.
Subscribe to GreatGameIndia
The co-inventor of the vaccine and U.S. Army lead for SpFN, Kayvon Modjarrad, praised and celebrated the development in a statement:
“Our strategy has been to develop a ‘pan-coronavirus’ vaccine technology that could potentially offer safe, effective and durable protection against multiple coronavirus strains and species.”
Modjarrad later added:
“This vaccine stands out in the COVID-19 vaccine landscape. The repetitive and ordered display of the coronavirus spike protein on a multi-faced nanoparticle may stimulate immunity in such a way as to translate into significantly broader protection.”
The military says the first human tests came to a conclusion early on this month, then later claiming that the vaccines proved themselves to be effective against the Omicron strain and “future strains.”
It is yet unclear how the claim regarding Omicron was possible since Omicron was initially discovered only by November 24th.
Out of the current 60 nanoparticle-based vaccines against COVID which were in clinical development, 26 have advanced onto the next phase of clinical trials.
29 participants have been registered into the first phase of the human trials with the SpFN vaccine. All 29 were evaluated to be healthy, between 18 and 55 years old, and have a BMI of less than 35 before they can participate in the study.
95% of deaths from COVID-19 occur in people over the age of 50. In addition, the vast majority of people who face dire complications as a result of Covid-19 are the elderly and/or have more than a few comorbidities.
All of the most common underlying complications of COVID-19 are linked to obesity. Hence, this study, which followed standard protocols, eliminated all participants exposed to the realistic threat of COVID-19.
Based on experimental data, the vaccine group was designed to have a ratio of 5: 1 compared to the placebo group. Given that only 29 of the 72 expected participants were enrolled in the Phase 1 study, this implies that the sample size of our control group is small – a potential control group of 5 people. Yes, an entirety of 5 whole human beings.
The news in the media and the military hype surrounding the pan-coronavirus cure are not only unjustifiable, but they are highly suspect.
In the meantime, merely a day prior to the military celebrating the clinical trials of Covid vaccines that can apparently cure all, Dr. Anthony Fauci and colleagues from the health Government Health issued a paper with the title of “Universal Coronavirus Vaccines — An Urgent Need.”